Company news
Anatara Lifesciences Ltd news in 2021
Anatara Lifesciences Ltd's news releases, calls and decks from 2021, newest first.
Change of Director's Interest Notice
December 12, 2021
Notification regarding unquoted securities - ANR
December 12, 2021
Application for quotation of securities - ANR
December 9, 2021
AGM CEO Presentation
November 16, 2021
Chairmans Address to Shareholders
November 16, 2021
AGM CEO Presentation
November 15, 2021
Appendix 4C & Q1 FY22 Activities Report
October 29, 2021
Anatara Lifesciences Limited (ASX: ANR) Annual Report to Shareholders
October 15, 2021
Investor Presentation
September 5, 2021
Appendix 4E & Financial Report 30 June 2021
August 24, 2021
Anatara Lifesciences Limited (ASX: ANR) Launches IBS-D Clinical Trial Recruitment Website
August 19, 2021
Successful Piglet Study
August 5, 2021
Monthly Activities/Appendix 4C Cash Flow Report
July 28, 2021
Anatara Lifesciences Limited (ASX: ANR) Monthly Activities Report
July 27, 2021
Anatara Lifesciences Limited (ASX: ANR) Chair Transition
July 25, 2021
Appendix 4C - quarterly
April 26, 2021
Anatara announces Australian patent grant for Detach
April 15, 2021
Market Update
April 7, 2021
Anatara Lifesciences Ltd (ASX: ANR) Completion of Unmarketable Parcel Share Buy-Back
February 9, 2021
Anatara Lifesciences Ltd Receives Ethics Approval to Start IBS Trial
February 7, 2021
Anatara Lifesciences Ltd (ASX: ANR) R&D Tax Incentive Received
February 2, 2021
Anatara Lifesciences Ltd (ASX: ANR) Successful Poultry Trial
January 31, 2021
Anatara Lifesciences Ltd (ASX: ANR) Quarterly Cash Report
January 27, 2021
Decks in 2021
- Shareholder Meeting (November 2021)
Shareholder meeting · 16 slides · Nov 16, 2021
- Investor Presentation (September 2021)
Investor deck · 24 slides · Sep 6, 2021